polycystic ovary syndrome
Conditions
Interventions
Sponsors
Fujian Provincial Maternal and Child Health Hospital
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Patients with PCOS: 1. Women between the ages of 20 and 40; 2. Scarce menstruation or amenorrhea or irregular uterine bleeding; 3. Hyperandrogenemia and/or clinical manifestations of hyperandrogenism (e.g., hirsutism, acne, seborrheic alopecia, etc.). 4. Ovarian polycystic changes: >=12 follicles of 2-9 mm in diameter and/or ovarian volume of >=10 cm^3 in one or both ovaries seen on ultrasound; 5. serum AMH levels are 2-3 times higher in women with PCOS than in normally ovulating women; 6. insulin resistance/hyperinsulinaemia or hyperlipidaemia; 7. subjects agree to the study and sign an informed consent form. Healthy women of childbearing age: 1. women between the ages of 20-40 years; 2. women who are not pregnant or not planning to become pregnant; 3. women without a definite diagnosis or symptoms related to PCOS; 4. women who are not in a stressful situation, such as severe anxiety, depression or chronic fatigue; 5. women who agree to participate in the study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. patients with polycystic ovary syndrome who refuse to sign the informed consent form; 2. other diseases that may cause hyperandrogenism and diseases that cause abnormal ovulation; 3. comorbid cardiac, pulmonary and haematopoietic diseases; 4. a combination of psychiatric disorders; 5. the use of hormonal drugs and drugs affecting the function of pancreatic islets within three months; 6. a combination of malignant tumours 7. have a combination of hereditary diseases 8. pregnancy or breastfeeding; 9. persons with a body mass index (BMI) 28 who are obese; 10. those who are allergic to the study test; those who have local skin damage at the detection points; those who have received acupuncture, cupping, tuina and other surface acupoint stimulation therapies within 1 week; those who do not wish to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glucose and lipid metabolism and endocrine hormone indicators;Ovulation rate;Indicators for acupoint sensitization detection; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM Syndrome Points; | — |
Countries
China
Contacts
Public ContactLin Ying
Fujian University of Traditional Chinese Medicine Qishan Campus
Outcome results
None listed